Jennifer Cook, MD, FAHA, FACC Appointed Global Medical Director at Itmar Medical

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Itmar Medical announced the appointment of Jennifer Cook, MD, FAHA, FACC to the newly created position of Global Medical Director, effective immediately. In this role, Dr. Cook will lead the Company’s continuing efforts in research, clinical and scientific priorities and oversee scientific collaboration with research institutes, medical associations, and key opinion leaders. She will report directly to Gilad Glick, President, and Chief Executive Officer.

“Jennifer has extensive expertise in the field of cardiology with a specific focus in Heart Failure, and her addition to the Itamar Medical team will enhance our ability to develop game-changing solutions to address the growing worldwide sleep apnea epidemic,” said Gilad Glick. “With 20 years of cardiology experience, her capabilities and understanding of the impact of sleep apnea on cardiac health are very aligned with our strategic initiatives to become the world leader in sleep apnea management solutions for the cardiology market. We look forward to her contributions and expect that she will be instrumental in helping us achieve our long-term objectives.”

“I know from my own experience treating patients that effective diagnosis and management of sleep apnea is essential for improving cardiovascular health and reducing the risk of serious health conditions,” said Dr. Cook. “Itamar Medical is at the forefront of innovating effective solutions for sleep apnea management, and I look forward to joining the Itamar Medical team at this exciting time in the Company’s growth.”

Dr. Cook is an attending physician in charge of the cardiovascular intensive care unit responsible for managing patients receiving mechanical circulatory support and extracorporeal membrane oxygenation at the University of Cincinnati. Previously, she was the associate professor, medical director, fellowship director and physician lead at the Banner University Medical Center at the University of Arizona. In this role, she revitalized the heart transplant program, increased patient volumes and improved outcomes in addition to a variety of other responsibilities. Prior to joining the University of Cincinnati, Dr. Cook was an associate professor and a medical director at the Medical University of South Carolina, where she developed the mechanical circulatory support (left ventricular assist) device program and served as principal investigator in multiple medical device and pharmaceutical clinical trials.

Dr. Cook earned her M.D. from Southern Illinois University. She completed her residency in Internal Medicine at the University of South Carolina and post-doctoral fellowships in Cardiovascular Disease and Advanced Heart Failure at Washington University in St. Louis.

 

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.